Cardiovascular Safety of Tocilizumab Versus Etanercept in Rheumatoid Arthritis: A Randomized Controlled Trial-Reference-Cited by-同舟云学术

Cardiovascular Safety of Tocilizumab Versus Etanercept in Rheumatoid Arthritis: A Randomized Controlled Trial

Published:2019-12-27 Issue:1 Volume:72 Page:31-40
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis Rheumatol

Author:

Giles Jon T.¹^ORCID,Sattar Naveed²,Gabriel Sherine³,Ridker Paul M.⁴,Gay Steffen⁵,Warne Charles⁶,Musselman David⁷,Brockwell Laura⁶,Shittu Emma⁶,Klearman Micki⁷,Fleming Thomas R.⁸

Affiliation:

1. Columbia University College of Physicians & Surgeons New York New York

2. University of Glasgow Glasgow UK

3. Rutgers Robert Wood Johnson Medical School New Brunswick New Jersey

4. Brigham and Women’s HospitalHarvard Medical School Boston Massachusetts

5. University Hospital Zurich Zurich Switzerland

6. Roche Products Ltd. Welwyn Garden City UK

7. Genentech, Inc. South San Francisco California

8. University of Washington Seattle

Funder

Roche

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.41095

Reference29 articles.

1. Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study

2. Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

3. Integrated safety in tocilizumab clinical trials

4. Lipid Profile Changes in Patients With Chronic Inflammatory Arthritis Treated With Biologic Agents and Tofacitinib in Randomized Clinical Trials: A Systematic Review and Meta-Analysis

5. Coronary arterial calcification in rheumatoid arthritis: comparison with the Multi-Ethnic Study of Atherosclerosis

Cited by 152 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of biologic agents and inflammation on lipid levels and cardiovascular risk in rheumatoid arthritis patients;Seminars in Arthritis and Rheumatism;2024-10

2. JAK inhibitor selectivity: new opportunities, better drugs?;Nature Reviews Rheumatology;2024-09-09

3. Current understanding and management of cardiovascular involvement in rheumatic immune-mediated inflammatory diseases;Nature Reviews Rheumatology;2024-09-02

4. Genetic and epigenetic regulation of inflammasomes: Role in atherosclerosis;Atherosclerosis;2024-09

5. Genetically Proxied IL-6 Receptor Inhibition and Coronary Artery Disease Risk in a Japanese Population;Clinical Therapeutics;2024-08